ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.67
      0.00%
      US Tech 100
      17,579.20
      -0.13%
      Dow Jones
      39,056.39
      0.44%
      Brent Oil
      84.045
      0.58%
      Bitcoin
      61,077.26
      -0.18%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Eton Pharmaceuticals Inc (ETON)

      7. Eton Pharmaceuticals Inc (ETON) News

      ETON

      Eton Pharmaceuticals (ETON)

      Eton Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ETON
      DateTimeSourceHeadlineSymbolCompany
      1:05PMiHub NewswireFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
      05/01/20244:05PMGlobeNewswire Inc.Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
      04/30/20247:00AMGlobeNewswire Inc.Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)NASDAQ:ETONEton Pharmaceuticals Inc
      04/29/20244:30PMGlobeNewswire Inc.Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ETONEton Pharmaceuticals Inc
      03/22/20242:00AMGlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for PhenylketonuriaNASDAQ:ETONEton Pharmaceuticals Inc
      03/14/20244:01PMGlobeNewswire Inc.Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
      02/29/20244:01PMGlobeNewswire Inc.Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024NASDAQ:ETONEton Pharmaceuticals Inc
      02/21/20246:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
      02/21/20246:50AMGlobeNewswire Inc.Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid FormulationNASDAQ:ETONEton Pharmaceuticals Inc
      02/15/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
      02/15/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
      02/15/20244:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
      02/02/20246:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
      02/02/20246:50AMGlobeNewswire Inc.Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone CapsulesNASDAQ:ETONEton Pharmaceuticals Inc
      11/09/20234:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
      11/09/20234:01PMGlobeNewswire Inc.Eton Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
      10/30/20236:50AMGlobeNewswire Inc.Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023NASDAQ:ETONEton Pharmaceuticals Inc
      10/18/20238:00AMPR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ETONEton Pharmaceuticals Inc
      10/04/20236:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
      10/04/20236:50AMGlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product NitisinoneNASDAQ:ETONEton Pharmaceuticals Inc
      08/23/20236:50AMGlobeNewswire Inc.Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
      08/10/20234:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
      08/10/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
      08/10/20234:01PMGlobeNewswire Inc.Eton Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
      08/01/20234:05PMGlobeNewswire Inc.Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023NASDAQ:ETONEton Pharmaceuticals Inc
      07/17/20234:05PMPR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ETONEton Pharmaceuticals Inc
      06/28/20237:42AMDow Jones NewsEton Pharma Gets FDA Complete Response Letter for Dehydrated Alcohol InjectionNASDAQ:ETONEton Pharmaceuticals Inc
      06/28/20236:56AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETONEton Pharmaceuticals Inc
      06/28/20236:50AMGlobeNewswire Inc.Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol InjectionNASDAQ:ETONEton Pharmaceuticals Inc
      06/15/20234:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETONEton Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ETON